335 related articles for article (PubMed ID: 33662324)
21. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
de Lusignan S; Dorward J; Correa A; Jones N; Akinyemi O; Amirthalingam G; Andrews N; Byford R; Dabrera G; Elliot A; Ellis J; Ferreira F; Lopez Bernal J; Okusi C; Ramsay M; Sherlock J; Smith G; Williams J; Howsam G; Zambon M; Joy M; Hobbs FDR
Lancet Infect Dis; 2020 Sep; 20(9):1034-1042. PubMed ID: 32422204
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 UK Biobank participants.
Gallacher KI; McQueenie R; Nicholl B; Jani BD; Lee D; Mair FS
J Comorb; 2018; 8(1):1-8. PubMed ID: 29492397
[TBL] [Abstract][Full Text] [Related]
23. Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study.
Ho FK; Celis-Morales CA; Gray SR; Katikireddi SV; Niedzwiedz CL; Hastie C; Ferguson LD; Berry C; Mackay DF; Gill JM; Pell JP; Sattar N; Welsh P
BMJ Open; 2020 Nov; 10(11):e040402. PubMed ID: 33444201
[TBL] [Abstract][Full Text] [Related]
24. Trends in the Prevalence of Chronic Non-Communicable Diseases and Multimorbidity across Socioeconomic Gradients in Rural Southwest China.
Liu L; Wu X; Li HF; Zhao Y; Li GH; Cui WL; Rabkin Golden A; Cai L
J Nutr Health Aging; 2023; 27(6):457-462. PubMed ID: 37357330
[TBL] [Abstract][Full Text] [Related]
25. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Causes of Death Collaborators
Lancet; 2017 Sep; 390(10100):1151-1210. PubMed ID: 28919116
[TBL] [Abstract][Full Text] [Related]
26. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants.
Hanlon P; Nicholl BI; Jani BD; Lee D; McQueenie R; Mair FS
Lancet Public Health; 2018 Jul; 3(7):e323-e332. PubMed ID: 29908859
[TBL] [Abstract][Full Text] [Related]
27. Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank.
Kolin DA; Kulm S; Christos PJ; Elemento O
PLoS One; 2020; 15(11):e0241264. PubMed ID: 33201886
[TBL] [Abstract][Full Text] [Related]
28. Association of socioeconomic and lifestyle factors with chronic non-communicable diseases and multimorbidity among the elderly in rural southwest China.
Li X; Cai L; Cui WL; Wang XM; Li HF; He JH; Golden AR
J Public Health (Oxf); 2020 May; 42(2):239-246. PubMed ID: 30860582
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.
Holman N; Knighton P; Kar P; O'Keefe J; Curley M; Weaver A; Barron E; Bakhai C; Khunti K; Wareham NJ; Sattar N; Young B; Valabhji J
Lancet Diabetes Endocrinol; 2020 Oct; 8(10):823-833. PubMed ID: 32798471
[TBL] [Abstract][Full Text] [Related]
30. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
[TBL] [Abstract][Full Text] [Related]
31. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
[TBL] [Abstract][Full Text] [Related]
32. COVID-19 vaccination during pregnancy: coverage and safety.
Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
[TBL] [Abstract][Full Text] [Related]
33. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort.
Sipilä PN; Heikkilä N; Lindbohm JV; Hakulinen C; Vahtera J; Elovainio M; Suominen S; Väänänen A; Koskinen A; Nyberg ST; Pentti J; Strandberg TE; Kivimäki M
Lancet Infect Dis; 2021 Nov; 21(11):1557-1567. PubMed ID: 34166620
[TBL] [Abstract][Full Text] [Related]
34. [Estimation of the impact of risk factors control on non-communicable diseases mortality, life expectancy and the labor force lost in China in 2030].
Zeng XY; Li YC; Liu JM; Liu YN; Liu SW; Qi JL; Zhou MG
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Dec; 51(12):1079-1085. PubMed ID: 29262488
[No Abstract] [Full Text] [Related]
35. The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort.
Foster HME; Ho FK; Mair FS; Jani BD; Sattar N; Katikireddi SV; Pell JP; Niedzwiedz CL; Hastie CE; Anderson JJ; Nicholl BI; Gill JMR; Celis-Morales C; O'Donnell CA
BMC Infect Dis; 2022 Mar; 22(1):273. PubMed ID: 35351028
[TBL] [Abstract][Full Text] [Related]
36. Social deprivation as a risk factor for COVID-19 mortality among women and men in the UK Biobank: nature of risk and context suggests that social interventions are essential to mitigate the effects of future pandemics.
Woodward M; Peters SAE; Harris K
J Epidemiol Community Health; 2021 Nov; 75(11):1050-1055. PubMed ID: 33906905
[TBL] [Abstract][Full Text] [Related]
37. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
38. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
39. Association of multimorbidity of non-communicable diseases with mortality: a 10-year prospective study of 0.5 million Chinese adults.
Zou S; Wang Z; Bhura M; Tang K
Public Health; 2022 Apr; 205():63-71. PubMed ID: 35240390
[TBL] [Abstract][Full Text] [Related]
40. Mortality-Air Pollution Associations in Low Exposure Environments (MAPLE): Phase 2.
Brauer M; Brook JR; Christidis T; Chu Y; Crouse DL; Erickson A; Hystad P; Li C; Martin RV; Meng J; Pappin AJ; Pinault LL; Tjepkema M; van Donkelaar A; Weagle C; Weichenthal S; Burnett RT
Res Rep Health Eff Inst; 2022 Jul; 2022(212):1-91. PubMed ID: 36224709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
